Skip Navigation

Awards and Honors

 ernesto bernal-mizrachi mdDr. Ernesto Bernal-Mizrach

 

Ernesto Bernal-Mizrachi, M.D., inducted into the ASCI medical honor society

 

ANN ARBOR, April 2010 — Ernesto Bernal-Mizrachi, M.D., U-M Brehm Investigator and Associate Professor of Internal Medicine in the Metabolism, Endocrinology & Diabetes Division, has been inducted into the American Society for Clinical Investigation (ASCI).

ASCI is one of the oldest and most esteemed organizations of physician-scientists. The induction took place at the ASCI/Association of American Physicians Joint Meeting in Chicago.

Candidates for ASCI membership are nominated by another ASCI member in a rigorous process that also requires secondary and supporting member recommendations. A Council for each scientific area reviews the nominations and determines the group that represents the best quality from the pool of nominations.

The names of those who make the cutoff are ultimately voted upon by the active membership. The maximum number of inductees across all the scientific disciplines is 80 per year; being chosen is a high professional honor.

Dr. Bernal joined the University of MIchigan faculty in 2009. The long-term goal of his laboratory is to understand the molecular mechanisms governing the regulation of beta-cell mass as a platform to develop novel strategies for the treatment of type 1 and 2 diabetes.

His lab's recent work has unraveled some of the molecular mechanisms of cellular plasticity and programming, demonstrating for the first time that activation of Akt signaling regulates the fate of differentiated pancreatic cells in vivo. These studies suggest that modulation of this pathway could be used to drive reprogramming to beta-cells as alternative therapy for diabetes.

For more information on Dr. Bernal's research, please see his lab website.